Experimental Therapeutics

The goal of this program is to develop clinician-scientists: individuals who are capable of conducting translational research integrating the biomedical and pharmaceutical sciences, while maintaining expertise as a clinician. The focus of this program is the development of basic research skills that facilitate the evaluation of mechanisms of disease processes and drug therapy. Find out more about the Division of Pharmacotherapy and Experimental Therapeutics.

Medicinal Chemistry

Medicinal Chemistry is a dynamic, multifaceted scientific discipline that is dedicated to the improvement of human health through research leading to new concepts for the design and development of therapeutic and diagnostic agents. The focus of Medicinal Chemistry is on biology, which distinguishes it from traditional chemistry, and it uses chemical tools, which distinguishes it from traditional biology. The field also has deep connections with medicine and molecular pharmacology. Research in Medicinal Chemistry is directed toward biomedical and pharmaceutical discovery by the application of both chemical and biological principles to interactions between molecular structure and biological activity. Find out more about the Division of Medicinal Chemistry and Natural Products.

Molecular Pharmaceutics

Molecular Pharmaceutics represents interdisciplinary specialties within the broad realm of the pharmaceutical sciences that encompass a range of scientific endeavors, including (1) the design, fabrication, evaluation, use of and delivery strategies for dosage forms, (2) elucidation of the behavior of pharmacologic agents in biologic systems, (3) determination of the ability of pharmacologic agents to reach the relevant site of biologic effect, and (4) determination of the time course of biologic activity. These areas of specialization represent critical steps in the development of new therapeutic agents, the evaluation of new and existing drugs in a variety of settings (e.g., potential interactions with other agents, alterations secondary to physiologic changes associated with disease processes), and the optimal clinical use of pharmacologic agents. Find out more about the Division of Molecular Pharmaceutics.

Pharmaceutical Outcomes and Policy

Research and education in Pharmaceutical Outcomes and Policy emphasizes an interdisciplinary approach to solving problems of developing, evaluating and distributing pharmaceutical products and services. Faculty research interests and course offerings within the division reflect this interdisciplinary orientation. 

Education and research in the division draws heavily upon expertise in numerous fields such as health policy, epidemiology, economics, and health behavior. DPOP emphasizes research in the area of evaluation of pharmaceutical care and/or pharmaceutical technologies. This includes assessment of processes and outcomes of care from economic, humanistic, and clinical perspectives. Much of the research involves drug policy-relevant research. Assessing and valuing pharmaceutical-related outcomes is a vital part of a broader mission to improve the performance of the health care system. Assessing and valuing outcomes in the pharmaceutical-related area is a vital part of this broader mission to improve the performance of the health care system. This is often exemplified in the formation and evaluation of drug policies. The pharmaceutical industry, governmental agencies, contract research organizations, academic institutions, managed care organizations, health insurance companies and private consulting firms are all in need of expertise in this area. Find out more about the Division of Pharmaceutical Outcomes and Policy.